TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia
![](https://medicine.nus.edu.sg/trp/n2cr/wp-content/uploads/sites/8/2023/10/Random-stash-of-designs-600x600-px-1-1024x1024.png)
This study, co-led by A/Prof Takaomi Sanda and A/Prof Allen Yeoh, delves into T-cell acute lymphoblastic leukemia (T-ALL), a difficult to treat form of blood cancer. In T-ALL, the mutated […]
PI3K/AKT/mTOR signalling transduction pathway and targeted therapies in cancer
![](https://medicine.nus.edu.sg/trp/n2cr/wp-content/uploads/sites/8/2023/10/Random-stash-of-designs-600x600-px--1024x1024.png)
The PI3K/AKT/mTOR (PAM) signaling pathway is crucial in regulating cell survival, growth, and the cell cycle. Its complex connections with other pathways can lead to cancer when disrupted. This review […]